Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery

Technology in Cancer Research and Treatment

Volumn 6, Issue 3, 2007, Pages 153-159

  Bhatnagar, A K ^a   Kondziolka, D ^a   Lunsford, L Dade ^a   Flickinger, John C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastases; Multiple brain metastases; Radiosurgery; RPA

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; FEMALE; GAMMA KNIFE RADIOSURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT INDICATION; VISCERAL METASTASIS;

EID: 34347397593     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460700600301     Document Type: Article

References (46)

1. Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, Kabbaj O, Spano JP, Marsiglia H, Rouzier R, Delaloge S, Spielmann M. Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol 22, 3302-3308 (2004).
2. Zabel A, Milker-Zabel S, Thilmann C, Zuna I, Rhein B, Wannenmacher M, Debus J. Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors. Lung Cancer 37, 87-94 (2002).
3. Van Poznak C, Seidman AD. Critical review of current treatment strategies for advanced hormone insensitive breast cancer. Cancer Invest. 20 1-14 (2002).
4. Smith IE. Aromatase inhibitors in early breast cancer therapy. Semin Oncol. 31, 9-14 (2004).
5. Sledge GW, Jr. Should we dream the impossible dream? The meaning of long-term survival in metastatic breast cancer. J Clin Oncol. 14 2191-2193 (1996).
6. Slimane K, Andre F, Delaloge S, Dunant A, Perez A, Grenier J, Massard C, Spielmann M. Risk factors for brain relapse in patients with metastatic breast cancer. Ann Oncol. 15 1640-1644 (2004).
7. Clayton AJ, Danson S, Jolly S, Ryder WD, Burt PA, Stewart AL, Wilkinson PM, Welch RS, Magee B, Wilson G, Howell A, Wardley AM. Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer 91, 639-643 (2004).
8. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B. Arandomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322 494-500 (1990).
9. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. Jama 280, 1485-1489 (1998).
10. Loeffler JS, Larson DA, Shrieve DC, Flickinger JC. Radiosurgery for the treatment of intracranial lesions. Important Adv Oncol, 141-156 (1995).
11. Lunsford LD, Flickinger J, Lindner G, Maitz A. Stereotactic radiosurgery of the brain using the first United States 201 cobalt-60 source gamma knife. Neurosurgery 24, 151-159 (1989).
12. Coffey RJ, Lunsford LD, Flickinger JC. The role of radiosurgery in the treatment of malignant brain tumors. Neurosurg Clin N Am 3, 231-244 (1992).
13. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ, Jr. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363 1665-1672 (2004).
14. Shaw EG, Gaspar LE, Gibbs FA, Lewin AA, Wharam MD, Jr., Larson D, Bloomer WD, Buckley JA, Loeffler JS, Malcolm AW, Mendenhall WM, Schneider JF, Schupak KD, Simpson JR, Gutin PH, Rogers L, Leibel S. Multiple brain metastases. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 1121-1128 (2000).
15. Bhatnagar AK, Flickinger, J.C., Kondziolka, D. Stereotactic Radiosurgery for Four or More Intracranial Metastases. Int J Radiat Oncol Biol Phys 64 898-903 (2006).
16. Ciampi A, Lawless JF, McKinney SM, Singhal K. Regression and recursive partition strategies in the analysis of medical survival data. J Clin Epidemiol 41 737-748 (1988).
17. Curran WJ, Jr., Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85, 704-710 (1993).
18. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37, 745-751 (1997).
19. Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47, 1001-1006 (2000).
20. Chougule PB B-WM, Saris S. Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy, or both. Int J Radiat Oncol Biol Phys 48, 114 (2000).
21. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45, 427-434 (1999).
22. Hasegawa T, Kondziolka D, Flickinger JC, Germanwala A, Lunsford LD. Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery 52, 1318-1326; discussion 26 (2003).
23. Flickinger JC, Kondziolka D, Lunsford LD, Coffey RJ, Goodman ML, Shaw EG, Hudgins WR, Weiner R, Harsh GR, Sneed PK. A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28 797-802 (1994).
24. Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, Regine WF, Weltman E, King VJ, Breneman JC, Sperduto PW, Mehta MP. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53, 519-526 (2002).
25. Kocher M, Maarouf M, Bendel M, Voges J, Muller RP, Sturm V. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol 180, 263-267 (2004).
26. Chidel MA, Suh JH, Reddy CA, Chao ST, Lundbeck MF, Barnett GH. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 47 993-999 (2000).
27. Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications. Am J Clin Oncol 28, 173-179 (2005).
28. Burri SH, Asher A, Shaffrey M. Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy? Neurosurgery 54, 1033-1034; author reply 34-35 (2004).
29. Chitapanarux I, Goss B, Vongtama R, Frighetto L, De Salles A, Selch M, Duick M, Solberg T, Wallace R, Cabatan-Awang C, Ford J. Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy. J Neurooncol 61, 143-149 (2003).
30. Regine WF, Huhn JL, Patchell RA, St Clair WH, Strottmann J, Meigooni A, Sanders M, Young AB. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 52, 333-338 (2002).
31. Weltman E, Salvajoli JV, Brandt RA, de Morais Hanriot R, Prisco FE, Cruz JC, de Oliveira Borges S, Lagatta M, Ballas Wajsbrot D. Radiosurgery for brain metastases: who may not benefit? Int J Radiat Oncol Biol Phys 51, 1320-1327 (2001).
32. Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, Gutin PH, Phillips TL, Wara WM, Larson DA. Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43, 549-558 (1999).
33. Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R, Wannenmacher M. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16, 3563-3569 (1998).
34. Shaw E, Scott C, Suh J, Kadish S, Stea B, Hackman J, Pearlman A, Murray K, Gaspar L, Mehta M, Curran W, Gerber M. RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database. J Clin Oncol 21, 2364-2371 (2003).
35. Abrey LE, Christodoulou C. Temozolomide for treating brain metastases. Semin Oncol 28 34-42 (2001).
36. Jawahar A, Ampil F, Wielbaecher C, Hartman GH, Zhang JH, Nanda A. Management strategies for patients with brain metastases: has radiosurgery made a difference? South Med J 97, 254-258 (2004).
37. Muacevic A, Siebels M, Tonn JC, Wowra B. Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery? World J Urol (2005).
38. Newton HB. Chemotherapy for the treatment of metastatic brain tumors. Expert Rev Anticancer Ther. 2, 495-506 (2002).
39. Ebert BL, Niemierko E, Shaffer K, Salgia R. Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer. Oncologist 8, 69-75 (2003).
40. Margolin K, Atkins B, Thompson A, Ernstoff S, Weber J, Flaherty L, Clark I, Weiss G, Sosman J, W IIS, Dutcher P, Gollob J, Longmate J, Johnson D. Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. J Cancer Res Clin Oncol 128 214-218 (2002).
41. Mehta MP, Rozental JM, Levin AB, Mackie TR, Kubsad SS, Gehring MA, Kinsella TJ. Defining the role of radiosurgery in the management of brain metastases. Int J Radiat Oncol Biol Phys 24 619-625 (1992),
42. McWilliams RR, Brown PD, Buckner JC, Link MJ, Markovic SN. Treatment of brain metastases from melanoma. Mayo Clin Proc. 78, 1529-1536 (2003).
43. Namba Y, Kijima T, Yokota S, Niinaka M, Kawamura S, Iwasaki T, Takeda Y, Kimura H, Okada T, Yamaguchi T, Nakagawa M, Okumura Y, Maeda H, Ito M. Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases. Clin Lung Cancer 6 123-128 (2004).
44. Semple PL, Denny L, Coughlan M, Soeters R, Van Wijk L. The role of neurosurgery in the treatment of cerebral metastases from choriocarcinoma: a report of two cases. Int J Gynecol Cancer 14, 157-161 (2004).
45. Poon AN, Ho SS, Yeo W, Mok TS. Brain metastasis responding to gefitinib alone. Oncology 67, 174-178 (2004).
46. Zabel A, Debus J, Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy. Lung Cancer 45 S247-S252 (2004).